Category: Tyco Healthcare
CareFusion, Tyco Healthcare and Cardinal Health land a collective $1 billion in supply contracts with the U.S. Dept. of Defense.
The United States Department of Defense awarded nearly $1.1 billion worth of contracts to 3 medical device firms.
Covidien could wind up with a nearly $450 million tax tab from its days as Tyco Healthcare, after the IRS nixes some $914 million in interest deductions dating back to the years 1997 through 2000.
A federal judge awards $177 million to Covidien in a patent infringement lawsuit with Johnson & Johnson's Ethicon Endo-Surgery subsidiary over ultrasonic scalpel technology.
UPDATED March 29, 2013, with comment from Covidien.
Tyco International, forebear of medical device industry titan Covidien, settles a federal bribery probe for $26 million after investigators find that Tyco Healthcare used illegal payments to influence doctors and public health professionals in Saudi Arabia, China and Poland.
Security giant Tyco International (NYSE:TYC), father of medical device company Covidien (NYSE:COV), agreed to pay a $26 million settlement to close the books on an international bribery scandal that involved health officials in Saudi Arabia, China and Poland.
European Union regulators are ready to OK Johnson & Johnson's $21.3 billion buyout of Synthes; also, Study: Patent-sharing the rising tide that lifts all boats; Standard & Poor's boosts CareFusion rating; Delcath inks Spanish training deal; Kozlowski is back in New York; DoD exercises option on $71M Zimmer contract; PE firm prepping for Medidata takeover?; C-level shifts at Alphatec prompt NASDAQ warning; PositiveID taps investor relations shop Trilogy Capital; plus, a Funding Roundup and analysts' ups and downs.
European Union regulators are poised to give the OK to Johnson & Johnson's (NYSE:JNJ) $21.3 billion acquisition of Swiss orthopedic giant Synthes, according to Reuters.
, CareFusion Corp.
, Delcath Systems Inc.
, Elliott Management
, Emergent Medical
, InVivo Therapeutics Corp.
, Johnson & Johnson
, Medidata Solutions
, PositiveID Corp.
, SpectraScience Inc.
, Standard & Poor's
, Stealth Therapeutics
, Synthes Inc.
, Tepha Inc.
, Trilogy Capital
, Tyco Healthcare
, U.S. Defense Dept.
, Vista Capital Partners
, Young Innovations
, Alphatec Spine Inc.
Following two decades at Kendall, Tyco Healthcare and Covidien, Richard Meelia rides off into the sunset at COV.
Richard Meelia, the CEO who led Covidien plc (NYSE:COV) in its various incarnations for more than two decades will hand over the keys to the corner officer to José (Joe) Almeida today without fanfare.
Meelia, 62, was named president & CEO of Covidien in June 2007, after it was spun out of the disintegrating Tyco International. He was elected chairman in October 2008 and has been with the company in its different forms for 20 years.
A U.S. Judicial Panel consolidates all actions filed against the DePuy over its Pinnacle metal-on-metal hip implant, setting the trial in the Lone Star State's northern district court under Judge James Kinkeade.
A group of at least 57 product liability lawsuits filed against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics over one of its metal-on-metal hip implants were consolidated in the U.S. District Court for Northern Texas.